Advertisement
Canada markets close in 5 hours 52 minutes
  • S&P/TSX

    21,858.17
    +149.73 (+0.69%)
     
  • S&P 500

    5,013.12
    +2.00 (+0.04%)
     
  • DOW

    37,985.86
    +210.48 (+0.56%)
     
  • CAD/USD

    0.7281
    +0.0017 (+0.24%)
     
  • CRUDE OIL

    82.78
    +0.05 (+0.06%)
     
  • Bitcoin CAD

    89,155.68
    +2,999.09 (+3.48%)
     
  • CMC Crypto 200

    1,383.19
    +70.56 (+5.69%)
     
  • GOLD FUTURES

    2,396.60
    -1.40 (-0.06%)
     
  • RUSSELL 2000

    1,950.47
    +7.51 (+0.39%)
     
  • 10-Yr Bond

    4.6130
    -0.0340 (-0.73%)
     
  • NASDAQ

    15,535.52
    -65.98 (-0.42%)
     
  • VOLATILITY

    18.36
    +0.36 (+2.00%)
     
  • FTSE

    7,852.99
    -24.06 (-0.31%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     

Is This Dividend King a Buy for Income Investors?

Is This Dividend King a Buy for Income Investors?

No matter which way the market goes, the payouts of companies with decades of dividend growth behind them tend to go in one direction: up. Abbott Laboratories' (NYSE: ABT) 50-year dividend growth streak makes it one of just 43 Dividend Kings. With 113,000 employees and a presence in more than 160 countries, Abbott is among the largest healthcare companies in the world.